Global Innovative Platforms (GIPL) Net Cash Flow Growth (3y) (2024 - 2026)
Powered by 
Analysis
Global Innovative Platforms (GIPL) Net Cash Flow Growth (3y) (2024 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | -29.30% |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | -5.41% |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | 17.73% |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | 18.48% |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | - |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | -217.27% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -217.27% |
| Mar 31, 2026 | 179.04% |
| Dec 31, 2025 | -273.56% |
| Sep 30, 2025 | -77.49% |
| Sep 30, 2024 | -153.12% |
| Jun 30, 2024 | -20.02% |